Aflac Incorporated (NYSE:AFL) Stock Holdings Boosted by Renasant Bank

Renasant Bank increased its position in Aflac Incorporated (NYSE:AFL) by 24.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,593 shares of the financial services provider’s stock after acquiring an additional 517 shares during the period. Renasant Bank’s holdings in Aflac were worth $268,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Franklin Resources Inc. increased its stake in shares of Aflac by 75.2% in the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after purchasing an additional 333,083 shares during the period. Aptus Capital Advisors LLC increased its position in Aflac by 79.7% in the 3rd quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock valued at $3,058,000 after acquiring an additional 12,131 shares during the period. Transamerica Financial Advisors Inc. bought a new stake in Aflac during the 3rd quarter valued at $979,000. Roxbury Financial LLC bought a new stake in Aflac during the 4th quarter valued at $948,000. Finally, FMR LLC boosted its position in Aflac by 4.0% during the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after acquiring an additional 45,745 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of a number of research analyst reports. Piper Sandler lowered their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Keefe, Bruyette & Woods lowered their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. JPMorgan Chase & Co. upped their price target on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Wells Fargo & Company lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Finally, Morgan Stanley boosted their price objective on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac has a consensus rating of “Hold” and an average target price of $103.36.

Insider Activity

In other news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares of the company’s stock, valued at $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by corporate insiders.

Aflac Stock Performance

Aflac stock opened at $104.95 on Friday. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50. The firm’s 50 day simple moving average is $105.29 and its 200-day simple moving average is $107.69. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company has a market cap of $57.37 billion, a P/E ratio of 10.93, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.